Daily Mirror – Print Edition
Daily FT
Sunday Times
Mirror Edu
Tamil Mirror
Lankadeepa
Middleast Lankadeepa
Ada
Deshaya
Life Online
Hi Online
E-Paper
Home delivery
Advertise with us
Mobile Apps
feedback
Archive
Print Ads
Tue, 03 Jun 2025   Today’s Paper
03 Jun 2025 – {{hitsCtrl.values.hits}}      
By Poojathmi Rivithma
Colombo, June 3 (Daily Mirror) – The Ministry of Health has clarified recent reports concerning the immunoglobulin drug manufactured by India's ICHOR Biologics Pvt Ltd. Registered in Sri Lanka in April 2023 after thorough evaluation by the National Medicines Regulatory Authority (NMRA), the drug faced temporary suspension following complaints about its quality.
Accordingly, the investigation by the National Drug Quality Assurance Laboratory and the Safety and Risk Assessment Subcommittee led to its withdrawal from use.
However, further analyses, including reports from India's Central Drug Quality Agency, confirmed that the drug met required standards. Consequently, the subcommittee recommended reinstating the drug for medical use.
The Ministry said that the Immunoglobulin currently in use is safe and effective, assuring the public of its commitment to maintaining high-quality healthcare standards.
1
2
3
4
5
6

03 Jun 2025 24 minute ago
03 Jun 2025 40 minute ago
03 Jun 2025 44 minute ago
03 Jun 2025 58 minute ago
03 Jun 2025 1 hours ago
General :
+94 0115 335 731
+94 0112 304 545
Circulation :
+94 0112 479 611
Advertising :
+94 0112 479 561
Subscription :
+94 0112 479 626
Technical :
+94 011 538 3437
[email protected]
All the content on this website is copyright protected and can be reproduced only by giving the due courtesy to ‘dailymirror.lk’ Copyright © 2004 Wijeya Newspapers Ltd.

source